Abbott Laboratories buy Wells Fargo & Company
Start price
13.12.23
/
50%
€98.55
Target price
13.12.24
€112.13
Performance (%)
-0.78%
Price
17:07
€96.76
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Abbott Laboratories is nearly unchanged. A total of €1.02 was paid as dividends for this prediction. This prediction currently runs until 13.12.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -1.587% | -1.587% |
| iShares Core DAX® | 1.851% | 5.158% |
| iShares Nasdaq 100 | 1.573% | 2.589% |
| iShares Nikkei 225® | -0.412% | -2.857% |
| iShares S&P 500 | 1.128% | 2.485% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Wells Fargo & Company from $116.00 to $121.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€93.86
05.04.23
05.04.23
€124.25
05.04.24
05.04.24
8.89%
06.04.24
06.04.24
